semaglutide injection diabetes Oral Shows Promise in Adolescents with Type 2 Diabetes Patients Also Struggle to

A higher concentration means smaller injection volumes but requires more precise measurements

Individual assessment by a prescribing clinician is essential, weighing the benefits of weight loss against potential gastrointestinal effects

Dungan reports research support from Abbott, Dexcom, Sanofi and ViaCyte

Patients in STEP trials experienced significant weight reductionsome losing 15% or more of their body weight over 68 weeks

Meyer CW, Ootsuka Y, Romanovsky AA

One patient with BMI 30kg/m 2 was included due to rapid weight rise during insulin intensification such that the patient did not want to proceed without co-management of weight gain